Genomics Personalized Health Market Size, Share, Growth Report 2032
Genomics Personalized Health Market By Technology (NGS platforms, RT-PCR, Microarray, and Genetic Analyzers), By Test Type (Oncology Testing, Infectious Disease Testing, Autoimmune Disease Testing, and Others), By End-User (Academics & Research Institutes, Diagnostic Centers, and Others), and By Region: Global Industry Perspective, Comprehensive Analysis and Forecast, 2024 - 2032
| Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 9.28 Billion | USD 31.01 Billion | 12.8% | 2023 |
Table Of Content
- Chapter No. 1 : Introduction
- 1.1. Report Description
- 1.1.1. Purpose of the Report
- 1.1.2. USP & Key Offerings
- 1.2. Key Benefits for Stakehulders
- 1.3. Target Audience
- 1.4. Report Scope
- 1.1. Report Description
- Chapter No. 2 : Executive Summary
- 2.1. Key Findings
- 2.1.1. Top Investment Pockets
- 2.1.1.1. Market Attractiveness Analysis, By Technulogy
- 2.1.1.2. Market Attractiveness Analysis, By Test Type
- 2.1.1.3. Market Attractiveness Analysis, By Regions
- 2.1.1. Top Investment Pockets
- 2.2. Investment Insights
- 2.3. Market Snapshot
- 2.4. Global Genomics Personalized Health Market, 2016 – 2028 (USD Million)
- 2.1. Key Findings
- Chapter No. 3 : COVID 19 Impact Analysis
- 3.1. Impact Assessment of COVID-19 Pandemic, By Region
- 3.2. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Million)
- 3.3. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Million)
- 3.4. Analyst View on COVID-19
- Chapter No. 4 : Genomics Personalized Health Market – Technulogy Segment Analysis
- 4.1. Overview
- 4.1.1. Market Revenue Share, By Technulogy, 2020 & 2028
- 4.2. NGS Platforms
- 4.2.1. Key Market Trends, Growth Factors, & Opportunities
- 4.3. RT-PCR
- 4.3.1. Key Market Trends, Growth Factors, & Opportunities
- 4.4. Microarray
- 4.4.1. Key Market Trends, Growth Factors, & Opportunities
- 4.5. Genetic Analyzers
- 4.5.1. Key Market Trends, Growth Factors, & Opportunities
- 4.1. Overview
- Chapter No. 5 : Genomics Personalized Health Market – Test Type Segment Analysis
- 5.1. Overview
- 5.1.1. Market Revenue Share, By Test Type, 2020 & 2028
- 5.2. Onculogy Testing
- 5.2.1. Key Market Trends, Growth Factors, & Opportunities
- 5.3. Infectious Disease Testing
- 5.3.1. Key Market Trends, Growth Factors, & Opportunities
- 5.4. Genetic Disease Testing
- 5.4.1. Key Market Trends, Growth Factors, & Opportunities
- 5.5. Autoimmune Disease Testing
- 5.5.1. Key Market Trends, Growth Factors, & Opportunities
- 5.6. Others
- 5.1. Overview
- Chapter No. 6 : Genomics Personalized Health Market – End User Segment Analysis
- 6.1. Overview
- 6.1.1. Market Revenue Share, By End User, 2020 & 2028
- 6.2. Research and Diagnostic Centers
- 6.2.1. Key Market Trends, Growth Factors, & Opportunities
- 6.3. Academics
- 6.3.1. Key Market Trends, Growth Factors, & Opportunities
- 6.4. Others
- 6.1. Overview
- Chapter No. 7 : Genomics Personalized Health Market – Regional Analysis
- 7.1. Overview
- 7.1.1. Global Market Revenue Share, By Region, 2020 & 2028
- 7.1.2. Global Market Revenue, By Region, 2016 – 2028 (USD Million)
- 7.2. North America
- 7.2.1. North America Market Revenue, By Country, 2016 – 2028 (USD Million)
- 7.2.2. North America Market Revenue, By Technulogy, 2016 – 2028
- 7.2.3. North America Genomics Personalized Health Market Revenue, By Test Type, 2016 – 2028
- 7.2.4. North America Genomics Personalized Health Market Revenue, By End User, 2016 – 2028
- 7.2.5. U.S.
- 7.2.5.1. U.S. Market Revenue, By Technulogy, 2016 – 2028
- 7.2.5.2. U.S. Genomics Personalized Health Market Revenue, By Test Type, 2016 – 2028
- 7.2.5.3. U.S. Genomics Personalized Health Market Revenue, By End User, 2016 – 2028
- 7.2.6. Canada
- 7.2.6.1. Canada Market Revenue, By Technulogy, 2016 – 2028
- 7.2.6.2. Canada Genomics Personalized Health Market Revenue, By Test Type, 2016 – 2028
- 7.2.6.3. Canada Genomics Personalized Health Market Revenue, By End User, 2016 – 2028
- 7.3. Europe
- 7.3.1. Europe Market Revenue, By Country, 2016 – 2028 (USD Million)
- 7.3.2. Europe Market Revenue, By Technulogy, 2016 – 2028
- 7.3.3. Europe Genomics Personalized Health Market Revenue, By Test Type, 2016 – 2028
- 7.3.4. Europe Genomics Personalized Health Market Revenue, By End User, 2016 – 2028
- 7.3.5. Germany
- 7.3.5.1. Germany Market Revenue, By Technulogy, 2016 – 2028
- 7.3.5.2. Germany Genomics Personalized Health Market Revenue, By Test Type, 2016 – 2028
- 7.3.5.3. Germany Genomics Personalized Health Market Revenue, By End User, 2016 – 2028
- 7.3.6. France
- 7.3.6.1. France Market Revenue, By Technulogy, 2016 – 2028
- 7.3.6.2. France Genomics Personalized Health Market Revenue, By Test Type, 2016 – 2028
- 7.3.6.3. France Genomics Personalized Health Market Revenue, By End User, 2016 – 2028
- 7.3.7. U.K
- 7.3.7.1. U.K Market Revenue, By Technulogy, 2016 – 2028
- 7.3.7.2. U.K Genomics Personalized Health Market Revenue, By Test Type, 2016 – 2028
- 7.3.7.3. U.K Genomics Personalized Health Market Revenue, By End User, 2016 – 2028
- 7.3.8. Italy
- 7.3.8.1. Italy Market Revenue, By Technulogy, 2016 – 2028
- 7.3.8.2. Italy Genomics Personalized Health Market Revenue, By Test Type, 2016 – 2028
- 7.3.8.3. Italy Genomics Personalized Health Market Revenue, By End User, 2016 – 2028
- 7.3.9. Spain
- 7.3.9.1. Spain Market Revenue, By Technulogy, 2016 – 2028
- 7.3.9.2. Spain Genomics Personalized Health Market Revenue, By Test Type, 2016 – 2028
- 7.3.9.3. Spain Genomics Personalized Health Market Revenue, By End User, 2016 – 2028
- 7.3.10. Rest of Europe
- 7.3.10.1. Rest of Europe Market Revenue, By Technulogy, 2016 – 2028
- 7.3.10.2. Rest of Europe Genomics Personalized Health Market Revenue, By Test Type, 2016 – 2028
- 7.3.10.3. Rest of Europe Genomics Personalized Health Market Revenue, By End User, 2016 – 2028
- 7.4. Asia Pacific
- 7.4.1. Asia Pacific Market Revenue, By Country, 2016 – 2028 (USD Million)
- 7.4.2. Asia Pacific Market Revenue, By Technulogy, 2016 – 2028
- 7.4.3. Asia Pacific Genomics Personalized Health Market Revenue, By Test Type, 2016 – 2028
- 7.4.4. Asia Pacific Genomics Personalized Health Market Revenue, By End User, 2016 – 2028
- 7.4.5. China
- 7.4.5.1. China Market Revenue, By Technulogy, 2016 – 2028
- 7.4.5.2. China Genomics Personalized Health Market Revenue, By Test Type, 2016 – 2028
- 7.4.5.3. China Genomics Personalized Health Market Revenue, By End User, 2016 – 2028
- 7.4.6. India
- 7.4.6.1. India Market Revenue, By Technulogy, 2016 – 2028
- 7.4.6.2. India Genomics Personalized Health Market Revenue, By Test Type, 2016 – 2028
- 7.4.6.3. India Genomics Personalized Health Market Revenue, By End User, 2016 – 2028
- 7.4.7. Japan
- 7.4.7.1. Japan Market Revenue, By Technulogy, 2016 – 2028
- 7.4.7.2. Japan Genomics Personalized Health Market Revenue, By Test Type, 2016 – 2028
- 7.4.7.3. Japan Genomics Personalized Health Market Revenue, By End User, 2016 – 2028
- 7.4.8. Korea
- 7.4.8.1. Korea Market Revenue, By Technulogy, 2016 – 2028
- 7.4.8.2. Korea Genomics Personalized Health Market Revenue, By Test Type, 2016 – 2028
- 7.4.8.3. Korea Genomics Personalized Health Market Revenue, By End User, 2016 – 2028
- 7.4.9. Southeast Asia
- 7.4.9.1. Southeast Asia Market Revenue, By Technulogy, 2016 – 2028
- 7.4.9.2. Southeast Asia Genomics Personalized Health Market Revenue, By Test Type, 2016 – 2028
- 7.4.9.3. Southeast Asia Genomics Personalized Health Market Revenue, By End User, 2016 – 2028
- 7.4.10. Rest of Asia Pacific
- 7.4.10.1. Rest of Asia Pacific Market Revenue, By Technulogy, 2016 – 2028
- 7.4.10.2. Rest of Asia Pacific Genomics Personalized Health Market Revenue, By Test Type, 2016 – 2028
- 7.4.10.3. Rest of Asia Pacific Genomics Personalized Health Market Revenue, By End User, 2016 – 2028
- 7.5. Latin America
- 7.5.1. Latin America Market Revenue, By Country, 2016 – 2028 (USD Million)
- 7.5.2. Latin America Market Revenue, By Technulogy, 2016 – 2028
- 7.5.3. Latin America Genomics Personalized Health Market Revenue, By Test Type, 2016 – 2028
- 7.5.4. Latin America Genomics Personalized Health Market Revenue, By End User, 2016 – 2028
- 7.5.5. Brazil
- 7.5.5.1. Brazil Market Revenue, By Technulogy, 2016 – 2028
- 7.5.5.2. Brazil Genomics Personalized Health Market Revenue, By Test Type, 2016 – 2028
- 7.5.5.3. Brazil Genomics Personalized Health Market Revenue, By End User, 2016 – 2028
- 7.5.6. Argentina
- 7.5.6.1. Argentina Market Revenue, By Technulogy, 2016 – 2028
- 7.5.6.2. Argentina Genomics Personalized Health Market Revenue, By Test Type, 2016 – 2028
- 7.5.6.3. Argentina Genomics Personalized Health Market Revenue, By End User, 2016 – 2028
- 7.5.7. Rest of Latin America
- 7.5.7.1. Rest of Latin America Market Revenue, By Technulogy, 2016 – 2028
- 7.5.7.2. Rest of Latin America Genomics Personalized Health Market Revenue, By Test Type, 2016 – 2028
- 7.5.7.3. Rest of Latin America Genomics Personalized Health Market Revenue, By End User, 2016 – 2028
- 7.6. MEA
- 7.6.1. MEA Market Revenue, By Country, 2016 – 2028 (USD Million)
- 7.6.2. MEA Market Revenue, By Technulogy, 2016 – 2028
- 7.6.3. MEA Genomics Personalized Health Market Revenue, By Test Type, 2016 – 2028
- 7.6.4. MEA Genomics Personalized Health Market Revenue, By End User, 2016 – 2028
- 7.6.5. GCC Countries
- 7.6.5.1. GCC Countries Market Revenue, By Technulogy, 2016 – 2028
- 7.6.5.2. GCC Countries Genomics Personalized Health Market Revenue, By Test Type, 2016 – 2028
- 7.6.5.3. GCC Countries Genomics Personalized Health Market Revenue, By End User, 2016 – 2028
- 7.6.6. South Africa
- 7.6.6.1. South Africa Market Revenue, By Technulogy, 2016 – 2028
- 7.6.6.2. South Africa Genomics Personalized Health Market Revenue, By Test Type, 2016 – 2028
- 7.6.6.3. South Africa Genomics Personalized Health Market Revenue, By End User, 2016 – 2028
- 7.6.7. Rest of MEA
- 7.6.7.1. Rest of MEA Market Revenue, By Technulogy, 2016 – 2028
- 7.6.7.2. Rest of MEA Genomics Personalized Health Market Revenue, By Test Type, 2016 – 2028
- 7.6.7.3. Rest of MEA Genomics Personalized Health Market Revenue, By End User, 2016 – 2028
- 7.1. Overview
- Chapter No. 8 : Genomics Personalized Health Market – Industry Analysis
- 8.1. Introduction
- 8.2. Market Drivers
- 8.2.1. Increasing Number of Genomic Personalized Medicine
- 8.2.2. Favorable Government Pulicies
- 8.2.3. Declining Cost and Improved Efficiency of Genomics Personalized Health
- 8.3. Market Restraints
- 8.3.1. Stringent Regulatory Pulicies
- 8.4. Opportunity
- 8.4.1. Increase Awareness among Public and Health Care Workforce
- 8.5. Porter’s Five Forces Analysis
- 8.5.1. Bargaining Power of Suppliers
- 8.5.2. Bargaining Power of Buyers
- 8.5.3. Threat of Substitute
- 8.5.4. Threat of New Entrants
- 8.5.5. Competitive Rivalry
- 8.6. Value Chain Analysis
- 8.7. PESTEL Analysis
- 8.8. Regulatory Framework
- Chapter No. 9 : Competitive Landscape
- 9.1. Company Market Share Analysis – 2019
- 9.1.1. Global Genomics Personalized Health Market: Company Market Share, 2019
- 9.1.2. Global Genomics Personalized Health Market, Company Market Revenue, 2019 (USD Million)
- 9.1. Company Market Share Analysis – 2019
- Chapter No. 10 : Company Profiles
- 10.1. Qiagen
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Portfulio
- 10.2. Thermo Fisher Scientific
- 10.2.1. Company Description
- 10.2.1.1. Operations
- 10.2.1.2. Geographic Reach
- 10.2.1.3. Sales and Marketing
- 10.2.2. Financial Performance
- 10.2.3. Product Portfulio
- 10.2.4. Strategy
- 10.2.5. Mergers and Acquisitions
- 10.2.1. Company Description
- 10.3. Bio-Rad Laboratories, Inc.
- 10.3.1. Company Description
- 10.3.1.1. Operations
- 10.3.1.2. Geographic Reach
- 10.3.1.3. Sales and Marketing
- 10.3.2. Financial Performance
- 10.3.3. Product Portfulio
- 10.3.4. Strategy
- 10.3.5. Mergers and Acquisitions
- 10.4. F. Hoffmann-La Roche Ltd.
- 10.4.1. Company Description
- 10.4.1.1. Operations
- 10.4.1.2. Geographic Reach
- 10.4.1.3. Sales and Marketing
- 10.4.2. Financial Performance
- 10.4.3. Product Portfulio
- 10.4.4. Strategy
- 10.4.5. Mergers and Acquisitions
- 10.3.1. Company Description
- 10.5. Lonza
- 10.5.1. Company Description
- 10.5.2. Company History
- 10.5.3. Product Portfulio
- 10.6. Illumina, Inc.
- 10.6.1. Company Description
- 10.6.1.1. Operations
- 10.6.1.2. Geographic Reach
- 10.6.1.3. Sales and Marketing
- 10.6.2. Financial Performance
- 10.6.3. Product Portfulio
- 10.6.4. Strategy
- 10.6.5. Mergers and Acquisitions
- 10.6.1. Company Description
- 10.7. Invitae Corporation
- 10.7.1. Company Description
- 10.7.2. Financial Performance
- 10.7.3. Product Portfulio
- 10.7.4. Key Development
- 10.8. Genetic Technulogies Limited
- 10.8.1. Company Description
- 10.8.2. Product Portfulio
- 10.9. DNA Genotek Inc.
- 10.9.1. Company Description
- 10.9.2. Product Portfulio
- 10.1. Qiagen
- Chapter No. 11 : Marketing Strategy Analysis
- 11.1. Marketing Channel
- 11.1. Direct Marketing
- 11.2. Indirect Marketing
- 11.3. Marketing Channel Development Trends
- Chapter No. 12 : Research Methodulogy
- 12.1. Research Methodulogy
- 12.2. Phase I - Secondary Research
- 12.3. Phase II - Data Modeling
- 12.3.1. Company Share Analysis Model
- 12.3.2. Revenue Based Modeling
- 12.4. Phase III - Primary Research
Table Of Figures
List of Figures
FIG NO. 1. Market Attractiveness Analysis, By Technology
FIG NO. 2. Market Attractiveness Analysis, By Test Type
FIG NO. 3. Market Attractiveness Analysis, By Regions
FIG NO. 4. Global Genomics Personalized Health Market Revenue, 2016 – 2028 (USD Million)
FIG NO. 5. Market Revenue Share, By Technology, 2020 & 2028
FIG NO. 6. Global Genomics Personalized Health Market for NGS platforms, Revenue (USD Million) 2016 – 2028
FIG NO. 7. Global Genomics Personalized Health Market for RT-PCR, Revenue (USD Million) 2016 – 2028
FIG NO. 8. Global Genomics Personalized Health Market for Microarray, Revenue (USD Million) 2016 – 2028
FIG NO. 9. Global Genomics Personalized Health Market for Genetic Analyzers, Revenue (USD Million) 2016 – 2028
FIG NO. 10. Market Revenue Share, By Test Type, 2020 & 2028
FIG NO. 11. Global Genomics Personalized Health Market for Oncology Testing, Revenue (USD Million) 2016 – 2028
FIG NO. 12. Global Genomics Personalized Health Market for Infectious Disease Testing, Revenue (USD Million) 2016 – 2028
FIG NO. 13. Global Genomics Personalized Health Market for Genetic Disease Testing, Revenue (USD Million) 2016 – 2028
FIG NO. 14. Global Genomics Personalized Health Market for Autoimmune Disease Testing, Revenue (USD Million) 2016 – 2028
FIG NO. 15. Global Genomics Personalized Health Market for Others, Revenue (USD Million) 2016 – 2028
FIG NO. 16. Market Revenue Share, By End User, 2020 & 2028
FIG NO. 17. Global Genomics Personalized Health Market for Research and Diagnostic Centers, Revenue (USD Million) 2016 – 2028
FIG NO. 18. Global Genomics Personalized Health Market for Academics, Revenue (USD Million) 2016 – 2028
FIG NO. 19. Global Genomics Personalized Health Market for Others, Revenue (USD Million) 2016 – 2028
FIG NO. 20. Global Genomics Personalized Health Market Revenue Share, By Region, 2020 & 2028
FIG NO. 21. North America Genomics Personalized Health Market Revenue, 2016 - 2028 (USD Million)
FIG NO. 22. Company Share Analysis, 2019
FIG NO. 23. Research Methodology – Detailed View
FIG NO. 24. Research Methodology
Table Of Tables
List of Tables
TABLE NO. 1. Global Genomics Personalized Health Market: Snapshot
TABLE NO. 2. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Million)
TABLE NO. 3. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Million)
TABLE NO. 4. Global Genomics Personalized Health Market Revenue, By Region, 2016 – 2028 (USD Million)
TABLE NO. 5. North America Genomics Personalized Health Market Revenue, By Country, 2016 – 2028 (USD Million)
TABLE NO. 6. North America Genomics Personalized Health Market Revenue, By Technology, 2016 – 2028 (USD Million)
TABLE NO. 7. North America Genomics Personalized Health Market Revenue, By Test Type, 2016 – 2028 (USD Million)
TABLE NO. 8. Genomics Personalized Health Market Revenue, By End User, 2016 – 2028 (USD Million)
TABLE NO. 9. U.S. Genomics Personalized Health Market Revenue, By Technology, 2016 – 2028 (USD Million)
TABLE NO. 10. U.S. Genomics Personalized Health Market Revenue, By Test Type, 2016 – 2028 (USD Million)
TABLE NO. 11. Genomics Personalized Health Market Revenue, By End User, 2016 – 2028 (USD Million)
TABLE NO. 12. Canada Genomics Personalized Health Market Revenue, By Technology, 2016 – 2028 (USD Million)
TABLE NO. 13. Canada Genomics Personalized Health Market Revenue, By Test Type, 2016 – 2028 (USD Million)
TABLE NO. 14. Genomics Personalized Health Market Revenue, By End User, 2016 – 2028 (USD Million)
TABLE NO. 15. Europe Genomics Personalized Health Market Revenue, By Country, 2016 – 2028 (USD Million)
TABLE NO. 16. Europe Genomics Personalized Health Market Revenue, By Technology, 2016 – 2028 (USD Million)
TABLE NO. 17. Europe Genomics Personalized Health Market Revenue, By Test Type, 2016 – 2028 (USD Million)
TABLE NO. 18. Genomics Personalized Health Market Revenue, By End User, 2016 – 2028 (USD Million)
TABLE NO. 19. Germany Genomics Personalized Health Market Revenue, By Technology, 2016 – 2028 (USD Million)
TABLE NO. 20. Germany Genomics Personalized Health Market Revenue, By Test Type, 2016 – 2028 (USD Million)
TABLE NO. 21. Genomics Personalized Health Market Revenue, By End User, 2016 – 2028 (USD Million)
TABLE NO. 22. France Genomics Personalized Health Market Revenue, By Technology, 2016 – 2028 (USD Million)
TABLE NO. 23. France Genomics Personalized Health Market Revenue, By Test Type, 2016 – 2028 (USD Million)
TABLE NO. 24. Genomics Personalized Health Market Revenue, By End User, 2016 – 2028 (USD Million)
TABLE NO. 25. U.K Genomics Personalized Health Market Revenue, By Technology, 2016 – 2028 (USD Million)
TABLE NO. 26. U.K Genomics Personalized Health Market Revenue, By Test Type, 2016 – 2028 (USD Million)
TABLE NO. 27. Genomics Personalized Health Market Revenue, By End User, 2016 – 2028 (USD Million)
TABLE NO. 28. Italy Genomics Personalized Health Market Revenue, By Technology, 2016 – 2028 (USD Million)
TABLE NO. 29. Italy Genomics Personalized Health Market Revenue, By Test Type, 2016 – 2028 (USD Million)
TABLE NO. 30. Genomics Personalized Health Market Revenue, By End User, 2016 – 2028 (USD Million)
TABLE NO. 31. Spain Genomics Personalized Health Market Revenue, By Technology, 2016 – 2028 (USD Million)
TABLE NO. 32. Spain Genomics Personalized Health Market Revenue, By Test Type, 2016 – 2028 (USD Million)
TABLE NO. 33. Genomics Personalized Health Market Revenue, By End User, 2016 – 2028 (USD Million)
TABLE NO. 34. Rest of Europe Genomics Personalized Health Market Revenue, By Technology, 2016 – 2028 (USD Million)
TABLE NO. 35. Rest of Europe Genomics Personalized Health Market Revenue, By Test Type, 2016 – 2028 (USD Million)
TABLE NO. 36. Genomics Personalized Health Market Revenue, By End User, 2016 – 2028 (USD Million)
TABLE NO. 37. Asia Pacific Genomics Personalized Health Market Revenue, By Country, 2016 – 2028 (USD Million)
TABLE NO. 38. Asia Pacific Genomics Personalized Health Market Revenue, By Technology, 2016 – 2028 (USD Million)
TABLE NO. 39. Asia Pacific Genomics Personalized Health Market Revenue, By Test Type, 2016 – 2028 (USD Million)
TABLE NO. 40. Genomics Personalized Health Market Revenue, By End User, 2016 – 2028 (USD Million)
TABLE NO. 41. China Genomics Personalized Health Market Revenue, By Technology, 2016 – 2028 (USD Million)
TABLE NO. 42. China Genomics Personalized Health Market Revenue, By Test Type, 2016 – 2028 (USD Million)
TABLE NO. 43. Genomics Personalized Health Market Revenue, By End User, 2016 – 2028 (USD Million)
TABLE NO. 44. India Genomics Personalized Health Market Revenue, By Technology, 2016 – 2028 (USD Million)
TABLE NO. 45. India Genomics Personalized Health Market Revenue, By Test Type, 2016 – 2028 (USD Million)
TABLE NO. 46. Genomics Personalized Health Market Revenue, By End User, 2016 – 2028 (USD Million)
TABLE NO. 47. Japan Genomics Personalized Health Market Revenue, By Technology, 2016 – 2028 (USD Million)
TABLE NO. 48. Japan Genomics Personalized Health Market Revenue, By Test Type, 2016 – 2028 (USD Million)
TABLE NO. 49. Genomics Personalized Health Market Revenue, By End User, 2016 – 2028 (USD Million)
TABLE NO. 50. Korea Genomics Personalized Health Market Revenue, By Technology, 2016 – 2028 (USD Million)
TABLE NO. 51. Korea Genomics Personalized Health Market Revenue, By Test Type, 2016 – 2028 (USD Million)
TABLE NO. 52. Genomics Personalized Health Market Revenue, By End User, 2016 – 2028 (USD Million)
TABLE NO. 53. Southeast Asia Genomics Personalized Health Market Revenue, By Technology, 2016 – 2028 (USD Million)
TABLE NO. 54. Southeast Asia Genomics Personalized Health Market Revenue, By Test Type, 2016 – 2028 (USD Million)
TABLE NO. 55. Genomics Personalized Health Market Revenue, By End User, 2016 – 2028 (USD Million)
TABLE NO. 56. Rest of Asia Pacific Genomics Personalized Health Market Revenue, By Technology, 2016 – 2028 (USD Million)
TABLE NO. 57. Rest of Asia Pacific Genomics Personalized Health Market Revenue, By Test Type, 2016 – 2028 (USD Million)
TABLE NO. 58. Genomics Personalized Health Market Revenue, By End User, 2016 – 2028 (USD Million)
TABLE NO. 59. Latin America Genomics Personalized Health Market Revenue, By Country, 2016 – 2028 (USD Million)
TABLE NO. 60. Latin America Genomics Personalized Health Market Revenue, By Technology, 2016 – 2028 (USD Million)
TABLE NO. 61. Latin America Genomics Personalized Health Market Revenue, By Test Type, 2016 – 2028 (USD Million)
TABLE NO. 62. Genomics Personalized Health Market Revenue, By End User, 2016 – 2028 (USD Million)
TABLE NO. 63. Brazil Genomics Personalized Health Market Revenue, By Technology, 2016 – 2028 (USD Million)
TABLE NO. 64. Brazil Genomics Personalized Health Market Revenue, By Test Type, 2016 – 2028 (USD Million)
TABLE NO. 65. Genomics Personalized Health Market Revenue, By End User, 2016 – 2028 (USD Million)
TABLE NO. 66. Argentina Genomics Personalized Health Market Revenue, By Technology, 2016 – 2028 (USD Million)
TABLE NO. 67. Argentina Genomics Personalized Health Market Revenue, By Test Type, 2016 – 2028 (USD Million)
TABLE NO. 68. Genomics Personalized Health Market Revenue, By End User, 2016 – 2028 (USD Million)
TABLE NO. 69. Rest of Latin America Genomics Personalized Health Market Revenue, By Technology, 2016 – 2028 (USD Million)
TABLE NO. 70. Rest of Latin America Genomics Personalized Health Market Revenue, By Test Type, 2016 – 2028 (USD Million)
TABLE NO. 71. Genomics Personalized Health Market Revenue, By End User, 2016 – 2028 (USD Million)
TABLE NO. 72. MEA Genomics Personalized Health Market Revenue, By Country, 2016 – 2028 (USD Million)
TABLE NO. 73. MEA Genomics Personalized Health Market Revenue, By Technology, 2016 – 2028 (USD Million)
TABLE NO. 74. MEA Genomics Personalized Health Market Revenue, By Test Type, 2016 – 2028 (USD Million)
TABLE NO. 75. Genomics Personalized Health Market Revenue, By End User, 2016 – 2028 (USD Million)
TABLE NO. 76. GCC Countries Genomics Personalized Health Market Revenue, By Technology, 2016 – 2028 (USD Million)
TABLE NO. 77. GCC Countries Genomics Personalized Health Market Revenue, By Test Type, 2016 – 2028 (USD Million)
TABLE NO. 78. Genomics Personalized Health Market Revenue, By End User, 2016 – 2028 (USD Million)
TABLE NO. 79. South Africa Genomics Personalized Health Market Revenue, By Technology, 2016 – 2028 (USD Million)
TABLE NO. 80. South Africa Genomics Personalized Health Market Revenue, By Test Type, 2016 – 2028 (USD Million)
TABLE NO. 81. Genomics Personalized Health Market Revenue, By End User, 2016 – 2028 (USD Million)
TABLE NO. 82. Rest of MEA Genomics Personalized Health Market Revenue, By Technology, 2016 – 2028 (USD Million)
TABLE NO. 83. Rest of MEA Genomics Personalized Health Market Revenue, By Test Type, 2016 – 2028 (USD Million)
TABLE NO. 84. Genomics Personalized Health Market Revenue, By End User, 2016 – 2028 (USD Million)
TABLE NO. 85. Drivers for the Genomics Personalized Health Market: Impact Analysis
TABLE NO. 86. Global Genomics Personalized Health Market, Company Market Revenue, 2019 (USD Million)
Methodology
FrequentlyAsked Questions
According to a study, the global Genomics Personalized Health market size was worth around USD 9.28 billion in 2023 and is expected to reach USD 31.01 billion by 2032.
The global Genomics Personalized Health market is expected to grow at a CAGR of 12.8% during the forecast period.
Some of the key factors driving the global genomics personalized health market growth are favorable government policies and increasing number of genomic personalized medicine.
North America is expected to dominate the Genomics Personalized Health market over the forecast period.
Some of the major companies operating in the Genomics Personalized Health Market are illumine, QIAGEN, Thermo Fisher Scientific, Bio-Rad Laboratories, Roche, Lonza Group, among others.
RelatedNews
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed